Streetbeat News

Analyst Ratings

OHI

Wells Fargo analyst Connor Siversky upgraded Omega Healthcare Invts (OHI) from Equal-Weight to Overweight and increased the price target from $31 to $35.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 10:43 am

SWN

Mizuho analyst Nitin Kumar upgraded Southwestern Energy (NYSE:SWN) from Underperform to Neutral and increased the price target from $6 to $9.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 10:41 am

SNCY

Morgan Stanley analyst Ravi Shanker upgrades Sun Country Airlines (SNCY) from Equal-Weight to Overweight with a new price target of $21.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 10:35 am

BRK

LI

NVDA

QQQ

SPY

US stocks may see a pause after a record rally, with caution returning ahead of key economic data. AI-leveraged stocks could provide support. Last week, buoyed by Nvidia's earnings, US stocks hit new highs. Analysts are optimistic about 2024, expecting narrow market focus and benefits from Fed rate cuts and election year optimism. Futures indicate a mixed opening. SPDR S&P 500 ETF Trust and Invesco QQQ ETF showed slight premarket movements. Key companies like Berkshire Hathaway and Li Auto saw premarket gains following earnings reports.

Portfolio Pulse from Shanthi Rexaline

February 26, 2024 | 10:33 am

AVB

Morgan Stanley analyst Adam Kramer upgraded AvalonBay Communities (AVB) from Equal-Weight to Overweight and increased the price target from $175 to $191.5. This adjustment reflects a more optimistic outlook on AVB's stock.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 10:32 am

ROOT

Keefe, Bruyette & Woods analyst Thomas McJoynt-Griffith upgrades Root Inc. (ROOT) from Market Perform to Outperform and raises the price target from $10 to $22.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 10:30 am

HCP

Morgan Stanley analyst Sanjit Singh has upgraded HashiCorp (NASDAQ:HCP) from Equal-Weight to Overweight and increased the price target from $23 to $30.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 10:29 am

INTA

Piper Sandler analyst Arvind Ramnani reiterated an Overweight rating on Intapp (NASDAQ:INTA) and maintained a $52 price target.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 10:25 am

HCAT

Keybanc analyst Scott Schoenhaus has maintained an Overweight rating on Health Catalyst (HCAT) but has lowered the price target from $12 to $10.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 10:23 am

DV

Keybanc analyst Justin Patterson maintains an Overweight rating on DoubleVerify Holdings (DV) and raises the price target from $40 to $48.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 10:21 am